COVID-19: Navigating the Pandemic: How will COVID-19 effect research studies and clinical trials?
April 16, 2020
Pharma companies, biotechs, governments, academic institutions, nonprofits and others are all racing to develop a treatment, a cure and a vaccine for COVID-19.
In this Sanguine Speaker Series (S3) virtual fireside chat, we will discuss:
- How will COVID-19 effect research studies and clinical trials?
- How do we ensure the safety of our patients test subjects?
- Will patients have safety concerns about participating in research studies or clinical trials after this pandemic?
- What is COVID-19’s potential impact on the global pharmaceutical market?
Independent Advisor, Former Head of Clinical Innovation
Vice President, Clinical Research Operations
Minneapolis Heart Institute Foundation
Editor in Chief
Sanguine, the leader in in-home specimen collection.